Sphere Power Inc.

A203690

KR7203690003

Personal Products

End-of-day quote Korea S.E. Other stock markets 03:30:00 04/07/2024 am IST			5-day change	1st Jan Change
5,550 ^KRW	-4.15%		-13.95%	-45.37%

27/03	Sangsangin Industry Co., Ltd. announced that it has received KRW 7.999999744 billion in funding from Sphere Power Inc.	CI
26/03	Sangsangin Industry Co., Ltd. announced that it expects to receive KRW 7.999999744 billion in funding from Sphere Power Inc.	CI

Prostemics Co., Ltd. agreed to acquire OTKCNT Co., Ltd. from Icure Pharmaceutical Incorporation and Gang, Seok-Ho for KRW 17 billion.

August 06, 2020

Prostemics Co., Ltd. (KOSDAQ:A203690) agreed to acquire OTKCNT Co., Ltd. from Icure Pharmaceutical Incorporation (KOSDAQ:A175250) and Gang, Seok-Ho for KRW 17 billion on August 6, 2020. As part of the transaction, Prostemics Co., Ltd. will acquire 90,000 shares from Icure Pharmaceutical Incorporation and 10,000 shares from Gang, Seok-Ho in OTKCNT Co., Ltd. In the year ended December 2019, OTKCNT Co., Ltd. reported total assets of KRW 11,794 million, sales of KRW 24,972 million and net income of KRW 1,410 million. Board of directors of Prostemics Co., Ltd. resolved the transaction and date of transfer of OTKCNT Co., Ltd. is August 7, 2020.

Latest news about Sphere Power Inc.

Sangsangin Industry Co., Ltd. announced that it has received KRW 7.999999744 billion in funding from Sphere Power Inc.	27/03	CI
Sangsangin Industry Co., Ltd. announced that it expects to receive KRW 7.999999744 billion in funding from Sphere Power Inc.	26/03	CI
Sphere Power Inc. announced that it has received KRW 27.59999252 billion in funding from Spear Power Association, Betsupply No. 1 Investment Cooperative, Aseka Holdings Co., Ltd. and another investor	21/12	CI
Sphere Power Inc. announced that it has received KRW 9.000004413 billion in funding	17/11	CI
Sphere Power Inc. announced extension to the offering period	11/23/11	CI
Sphere Power Inc. announced extension to the offering period	12/23/12	CI
An unknown buyer agreed to acquire a 10.89% stake in Prostemics Co., Ltd. from Leaders Cosmetics Co., Ltd. for KRW 7.9 billion	23/23/23	CI
Prostemics Co., Ltd. announced that it expects to receive KRW 11.999995778 billion in funding	23/23/23	CI
Prostemics Co., Ltd. announced that it expects to receive KRW 999.995788 million in funding	23/23/23	CI
Prostemics Co., Ltd. announced that it expects to receive KRW 23 billion in funding from Spear Power Association	31/23/31	CI
An unknown buyer entered into an agreement to acquire Egnis Inc. from Prostemics Co., Ltd. for KRW 1.5 billion.	30/23/30	CI
Prostemics Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	15/23/15	CI
Prostemics Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022	24/23/24	CI
Prostemics Co., Ltd. announced that it has received KRW 6 billion in funding from Sangsangin Savings Bank, Sangsangin Plus Savings Bank Co.,Ltd.	17/22/17	CI
Prostemics Co., Ltd. announced that it expects to receive KRW 6 billion in funding from Sangsangin Savings Bank, Sangsangin Plus Savings Bank Co.,Ltd.	13/22/13	CI
Prostemics Co., Ltd.(KOSDAQ:A203690) dropped from S&P Global BMI Index	19/22/19	CI
Prostemics Co., Ltd. announced that it has received KRW 5 billion in funding	25/22/25	CI
Prostemics Co., Ltd. announced that it expects to receive KRW 5 billion in funding	24/22/24	CI
Prostemics Co., Ltd. announced that it has received KRW 9.999997408 billion in funding	27/22/27	CI
Prostemics Co., Ltd. announced that it expects to receive KRW 9.999997408 billion in funding	25/22/25	CI
Prostemics : California weed supplier HERBL in talks to go public via SPAC merger - sources	12/21/12	RE
Prostemics : California weed supplier HERBL in talks to go public via SPAC merger - sources	12/21/12	RE
Prostemics : Investors brace for annual Russell index rebalancing with pandemic imprint	21/21/21	RE
Prostemics : Investors brace for annual Russell index rebalancing with pandemic imprint	18/21/18	RE
Prostemics Co., Ltd. agreed to acquire OTKCNT Co., Ltd. from Icure Pharmaceutical Incorporation and Gang, Seok-Ho for KRW 17 billion.	06/20/06	CI

Chart Sphere Power Inc.

Duration

Period

More charts

Company Profile

Sphere Power Inc is a Korea-based company engaged in the business of manufacturing stem cell culture fluid cosmetics. The Company operates through two segments. The Household Health Business segment engages in weeding and sales of wet wipes. The Bio Business segment is engaged in the research and development of pharmaceuticals, cosmetics, and health functional foods. In addition, this segment is engaged in the bio business, such as the development of inflammatory bowel disease (IBD) treatment using microbiome exosomes, intestinal health functional food, and anticancer treatment.

Sector

Personal Products

Calendar

13/08/2024 - Q2 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Sector Cosmetics & Perfumes

	1st Jan change	Capi.
SPHERE POWER INC.	-45.37%	51.85M
L'ORÉAL	-9.46%	234B
GALDERMA GROUP AG	0.00%	19.64B
KAO CORPORATION	+13.02%	18.9B
SHISEIDO COMPANY, LIMITED	+8.30%	11.47B
COTY INC.	-21.66%	8.4B
AMOREPACIFIC CORPORATION	+2.55%	6.72B
PROYA COSMETICS CO.,LTD.	+1.32%	5.55B
NATURA &CO HOLDING S.A.	-7.99%	3.88B
INTER PARFUMS, INC.	-20.64%	3.66B